ProScribe - part of the Envision Pharma Group

ProScribe, now part of the Envision Pharma Group, delivers exceptional medical communication services to leading international pharmaceutical, biotechnology, and academic organizations. Following its merger with Envision Pharma Group, ProScribe offers expanded geographic reach, enhanced resources, and a broader spectrum of services, including market access, medical affairs, and publication software solutions. The primary address for ProScribe is Noosaville, Queensland, 4566, AU. Additional locations include Level 23, Citigroup Tower, 33 Huayuanshiqiao Road, Shanghai, 200120, CN; Level 20, Marunouchi Trust Tower - Main, 1-8-3 Marunouchi, Chiyoda-Ku, Tokyo 100-0005, JP; Sydney, NSW, 2000, AU; and Melbourne, Victoria, 3000, AU.

ProScribe specializes in creating scientifically credible and high-quality medical documents. With extensive industry and academic experience across numerous therapeutic areas, ProScribe excels in publication planning and the development of regulatory and educational documents. This includes slide presentations, clinical study reports, manuscripts, protocols, continuing professional development programs, and posters.

Founded in 2000, ProScribe is dedicated to providing top-tier services in medical writing and communication. ProScribe is committed to supporting the advancement of medical knowledge and improving patient outcomes. We invite the manager of ProScribe to create a customized and exclusive company showcase and product listing on our platform to further enhance their visibility and commercial development.